Insiders · Profile

HALKUFF DAWN

Director at Xeris Biopharma. Filing since 20 Nov 2023. CIK 0001743658

Company
Date
Role
Action
Shares
Amount
Of holding
4 Jun 2026
Director
Sold on a plan
20,000
$121.89K
17.4%
12 Aug 2025
Director
Sold at will
42,500
$309.23K
27.0%
20 Nov 2023
Director
Bought
5,410
$9.95K
opened
3 decisions on file.